Gene therapy for ovarian cancer (review)

  • Authors:
    • Judith K. Wolf
    • A. Dwayne Jenkins
  • View Affiliations

  • Published online on: September 1, 2002     https://doi.org/10.3892/ijo.21.3.461
  • Pages: 461-468
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The field of gene therapy presents exciting new opportunities for advances in the management of ovarian cancer. Clinical trials of gene therapy for ovarian cancer have explored the feasibility of delivering a variety of agents as well as highlighted problems with the delivery of therapeutic constructs. Major challenges include enhancing gene transfection with improved vectors, minimizing immunogenicity of viral vectors via novel molecular alterations, effecting tumor-selective gene delivery by targeting genetic alterations present only in tumor cells and utilizing tissue-specific promoters for selective transcription of gene products. Gene therapy research presents unique opportunities for extending the spectrum of ovarian cancer treatment possibilities, either alone or in combination with conventional chemotherapy regimens.

Related Articles

Journal Cover

September 2002
Volume 21 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wolf JK and Jenkins AD: Gene therapy for ovarian cancer (review). Int J Oncol 21: 461-468, 2002.
APA
Wolf, J.K., & Jenkins, A.D. (2002). Gene therapy for ovarian cancer (review). International Journal of Oncology, 21, 461-468. https://doi.org/10.3892/ijo.21.3.461
MLA
Wolf, J. K., Jenkins, A. D."Gene therapy for ovarian cancer (review)". International Journal of Oncology 21.3 (2002): 461-468.
Chicago
Wolf, J. K., Jenkins, A. D."Gene therapy for ovarian cancer (review)". International Journal of Oncology 21, no. 3 (2002): 461-468. https://doi.org/10.3892/ijo.21.3.461